These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2551057)

  • 1. Plasmin's peptide-binding specificity: characterization of ligand sites in alpha 2-antiplasmin.
    Hortin GL; Trimpe BL; Fok KF
    Thromb Res; 1989 Jun; 54(6):621-32. PubMed ID: 2551057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha 2-antiplasmin's carboxy-terminal lysine residue is a major site of interaction with plasmin.
    Hortin GL; Gibson BL; Fok KF
    Biochem Biophys Res Commun; 1988 Sep; 155(2):591-6. PubMed ID: 2458720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of conserved lysine residues in the alpha2-antiplasmin C terminus to plasmin binding and inhibition.
    Lu BG; Sofian T; Law RH; Coughlin PB; Horvath AJ
    J Biol Chem; 2011 Jul; 286(28):24544-52. PubMed ID: 21543325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E; Thorsen S
    Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of the reactions between streptokinase, plasmin and alpha 2-antiplasmin.
    Cederholm-Williams SA; De Cock F; Lijnen HR; Collen D
    Eur J Biochem; 1979 Oct; 100(1):125-32. PubMed ID: 158524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of amino acids in antiplasmin involved in its noncovalent 'lysine-binding-site'-dependent interaction with plasmin.
    Wang H; Yu A; Wiman B; Pap S
    Eur J Biochem; 2003 May; 270(9):2023-9. PubMed ID: 12709062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A monoclonal antibody directed against the high-affinity lysine-binding site (LBS) of human plasminogen. Role of LBS in the regulation of fibrinolysis.
    Holvoet P; Lijnen HR; Collen D
    Eur J Biochem; 1986 May; 157(1):65-9. PubMed ID: 2940088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha 2-antiplasmin Enschede is not an inhibitor, but a substrate, of plasmin.
    Rijken DC; Groeneveld E; Kluft C; Nieuwenhuis HK
    Biochem J; 1988 Oct; 255(2):609-15. PubMed ID: 2974279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of soluble fibrin on reaction kinetics of plasmin type 1 and type 2 with alpha2-antiplasmin.
    Ries M; Zenker M
    Blood Coagul Fibrinolysis; 2003 Feb; 14(2):203-9. PubMed ID: 12632033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated thrombin-activatable fibrinolysis inhibitor reduces the ability of high molecular weight fibrin degradation products to protect plasmin from antiplasmin.
    Schneider M; Brufatto N; Neill E; Nesheim M
    J Biol Chem; 2004 Apr; 279(14):13340-5. PubMed ID: 14715654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a synthetic carboxy-terminal peptide of alpha(2)-antiplasmin on urokinase-induced fibrinolysis.
    Lee KN; Jackson KW; McKee PA
    Thromb Res; 2002 Feb; 105(3):263-70. PubMed ID: 11927133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the interaction of human plasmin with its specific receptor on a group A streptococcus.
    Broeseker TA; Boyle MD; Lottenberg R
    Microb Pathog; 1988 Jul; 5(1):19-27. PubMed ID: 2977421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-sepharose, and fibrin cleaved by plasmin.
    Bok RA; Mangel WF
    Biochemistry; 1985 Jun; 24(13):3279-86. PubMed ID: 3161540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding site of alpha 2-plasmin inhibitor to plasminogen.
    Sugiyama N; Sasaki T; Iwamoto M; Abiko Y
    Biochim Biophys Acta; 1988 Jan; 952(1):1-7. PubMed ID: 3334852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reaction of human alpha2-antiplasmin and plasmin stopped-flow fluorescence kinetics.
    Christensen U; Bangert K; Thorsen S
    FEBS Lett; 1996 May; 387(1):58-62. PubMed ID: 8654567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen.
    Wiman B; Lijnen HR; Collen D
    Biochim Biophys Acta; 1979 Jul; 579(1):142-54. PubMed ID: 157166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Features of the interaction between alpha2-antiplasmin and plasminogen/plasmin].
    Hrynenko TV; Iusova OI; Zadorozhna MB; Makohonenko IeM
    Ukr Biokhim Zh (1999); 2002; 74(6):83-90. PubMed ID: 12924019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen binding by alpha 2-antiplasmin and histidine-rich glycoprotein does not inhibit plasminogen activation at the surface of fibrin.
    Angles-Cano E; Rouy D; Lijnen HR
    Biochim Biophys Acta; 1992 Dec; 1156(1):34-42. PubMed ID: 1472536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human alpha(2)-plasmin inhibitor: functional characterization of the unique plasmin(ogen)-binding region.
    Gerber SS; Lejon S; Locher M; Schaller J
    Cell Mol Life Sci; 2010 May; 67(9):1505-18. PubMed ID: 20112045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
    Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
    Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.